US4910190A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Peptide derivatives
Assignee: Syngenta Ltd
•
Filing: 1987-01-20
•
Granted: 1990-03-20
•
Expires: 2007-01-20
Abstract
Abstract The invention concerns pharmaceutically useful trifluoromethyl ketone substituted di-, tri- and tetra-peptide derivatives of the formulae Ia, Ib, Ic set out hereinafter, and salts thereof, which are inhibitors of human leukocyte elastase. Also described herein are pharmaceutical compositions containing a peptide derivative and processes and intermediates for use in the manufacture of the peptide derivatives.
Inventors
- 👤 Scott H. Bergeson
- 👤 Philip D. Edwards
- 👤 John A. Schwartz
- 👤 Andrew Shaw
- 👤 Mark M. Stein
- 👤 Diane A. Trainor
- 👤 Richard A. Wildonger
- 👤 Donald J. Wolanin
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 03:24
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/10; C07C; C07C205/00; C07C205/13; C07C205/26; A; A61; A61P; A61P11/00; A61P29/00; A61P43/00; A61P9/00; A61P9/10; C07C205/01; C07C205/02; C07C205/39; C07C205/42; C07C205/43; C07K5/06; C07K5/06191; C07K5/08; C07K5/0819; C07K5/0827; A61K; A61K38/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
655 words
A compound of formula Ia, Ib or Ic: ##STR5## wherein R 1 is an alkyl group containing from 1 to 5 carbon atoms; R 2 and R 5 are each selected independently from the group consisting of: (I) an alkyl group containing from 1 to 10 carbons; and (II) an alkyl group containing from 1 to 6 carbon atoms substituted by at least one member selected from the group consisting of: (a) hydroxy; (b) amino; (c) alkylamino containing from 1 to 6 carbons; (d) dialkylamino wherein each alkyl group contains from 1 to 6 carbons; (e) alkanoyl containing from 1 to 6 carbons; (f) arylcarbonyl wherein the aryl contains 6, 10 or 12 carbons; (g) aralkanoyl containing 8 to 13 carbons; (h) amido which may be attached to the alkyl group via either a nitrogen or carbon of said amido; (i) alkylcarbonylamino wherein the alkyl group contains from 1 to 6 carbons; (j) alkylaminocarbonyl wherein the alkyl group contains from 1 to 6 carbons; (k) arylcarbonylamino wherein the aryl group contains 6, 10 or 12 carbons; (l) aralkylcarbonylamino wherein the aralkyl group contains from 7 to 13 carbons; (m) arylaminocarbonyl wherein the aryl group contains 6, 10 or 12 carbons; (n) aralkylaminocarbonyl wherein the aralkyl group contains from 7 to 13 carbons; (o) carboxy; (p) aryloxycarbonyl wherein the aryl group contains 6, 10 or 12 carbons; (q) aralkoxycarbonyl wherein the aralkoxy group contains from 7 to 13 carbons; (r) alkanoyloxy containing from 1 to 6 carbons; (s) aroyloxy wherein the aryl portion contains 6, 10 or 12 carbons; (t) aralkanoyloxy containing from 8 to 14 carbons; (u) alkylsulfonamido wherein the alkyl group contains from 1 to 6 carbons; (v) aralkylsulfonamido wherein the aralkyl group contains from 7 to 13 carbons; (w) arylsulfonamido wherein the aryl group contains 6, 10 or 12 carbons; (x) acylsulfonamido (i.e. acylaminosulfonyl and sulfonylaminocarbonyl) including acylsulfonamido wherein the acyl group contains 1 to 7 carbons when it is the terminal portion of the acylsulfonamide and provided that when the acylsulfonamido contains an aryl the aryl may be further substituted by a member selected from fluoro, chloro, bromo, iodo and nitro; (y) alkoxycarbonyl wherein the alkoxy group contains from 1 to 6 carbons; (z) aralkoxycarbonylamino wherein the aralkoxy group contains from 8 to 13 carbons; (aa) aryloxycarbonylamino wherein the aryloxy group contains 6, 10 or 12 carbons; (bb) alkoxycarbonylamino wherein the alkyloxy group contains from 1 to 6 carbons; (cc) aryl containing 6, 10 or 12 carbons; (dd) aryl containing 6, 10 or 12 carbons and substituted by 1 to 3 members selected from the group consisting of chloro, bromo, iodo, fluoro, trifluoromethyl, hydroxy, alkyl (1 to 6 carbons), alkoxy (1 to 6 carbons), alkoxycarbonyl (1 to 6 carbons), carboxy, 5-tetrazolo, and acylsufonamido (i.e. acylaminosulfonyl and sulfonylaminocarbonyl) (1 to 15 carbons) and provided that when the acylsulfonamido contains an aryl the aryl may be further substituted by a member selected from fluoro, chloro, bromo, iodo and nitro; (ee) cycloalkyl containing from 3 to 15 carbons; (ff) alkylureido wherein the alkyl group contains from 1 to 6 carbons; (gg) aralkylureido wherein the aralkyl group contains from 8 to 13 carbons; (hh) arylureido wherein the aryl group contains 6, 10 or 12 carbons; R 3 is an aryl group containing 6, 10 or 12 carbons suitably substituted by acylsulfonamido (i.e. acylaminosulfonyl and sulfonylaminocarbonyl) containing from 1 to 15 carbons, and provided that when the acylsulfonamido contains an aryl the aryl may be further substituted by fluoro, chloro, bromo, iodo or nitro; R 4 and R 6 are independently hydrogen or methyl; n is 0, 1 or 2; and A is selected from the group consisting of ##STR6## and where appropriate, the acid- and base-addition salts thereof and provided that: (1) alkyls may be straight or branched chain; (2) no carbon of an alkyl may be directly bonded to two heteroatoms; and (3) no heteroatom may be directly bonded to a sulfur, nitrogen or oxygen.
Claim 2
Dependent Claim
655 words
A compound of formula Ia, Ib or Ic: ##STR5## wherein R 1 is an alkyl group containing from 1 to 5 carbon atoms; R 2 and R 5 are each selected independently from the group consisting of: (I) an alkyl group containing from 1 to 10 carbons; and (II) an alkyl group containing from 1 to 6 carbon atoms substituted by at least one member selected from the group consisting of: (a) hydroxy; (b) amino; (c) alkylamino containing from 1 to 6 carbons; (d) dialkylamino wherein each alkyl group contains from 1 to 6 carbons; (e) alkanoyl containing from 1 to 6 carbons; (f) arylcarbonyl wherein the aryl contains 6, 10 or 12 carbons; (g) aralkanoyl containing 8 to 13 carbons; (h) amido which may be attached to the alkyl group via either a nitrogen or carbon of said amido; (i) alkylcarbonylamino wherein the alkyl group contains from 1 to 6 carbons; (j) alkylaminocarbonyl wherein the alkyl group contains from 1 to 6 carbons; (k) arylcarbonylamino wherein the aryl group contains 6, 10 or 12 carbons; (l) aralkylcarbonylamino wherein the aralkyl group contains from 7 to 13 carbons; (m) arylaminocarbonyl wherein the aryl group contains 6, 10 or 12 carbons; (n) aralkylaminocarbonyl wherein the aralkyl group contains from 7 to 13 carbons; (o) carboxy; (p) aryloxycarbonyl wherein the aryl group contains 6, 10 or 12 carbons; (q) aralkoxycarbonyl wherein the aralkoxy group contains from 7 to 13 carbons; (r) alkanoyloxy containing from 1 to 6 carbons; (s) aroyloxy wherein the aryl portion contains 6, 10 or 12 carbons; (t) aralkanoyloxy containing from 8 to 14 carbons; (u) alkylsulfonamido wherein the alkyl group contains from 1 to 6 carbons; (v) aralkylsulfonamido wherein the aralkyl group contains from 7 to 13 carbons; (w) arylsulfonamido wherein the aryl group contains 6, 10 or 12 carbons; (x) acylsulfonamido (i.e. acylaminosulfonyl and sulfonylaminocarbonyl) including acylsulfonamido wherein the acyl group contains 1 to 7 carbons when it is the terminal portion of the acylsulfonamide and provided that when the acylsulfonamido contains an aryl the aryl may be further substituted by a member selected from fluoro, chloro, bromo, iodo and nitro; (y) alkoxycarbonyl wherein the alkoxy group contains from 1 to 6 carbons; (z) aralkoxycarbonylamino wherein the aralkoxy group contains from 8 to 13 carbons; (aa) aryloxycarbonylamino wherein the aryloxy group contains 6, 10 or 12 carbons; (bb) alkoxycarbonylamino wherein the alkyloxy group contains from 1 to 6 carbons; (cc) aryl containing 6, 10 or 12 carbons; (dd) aryl containing 6, 10 or 12 carbons and substituted by 1 to 3 members selected from the group consisting of chloro, bromo, iodo, fluoro, trifluoromethyl, hydroxy, alkyl (1 to 6 carbons), alkoxy (1 to 6 carbons), alkoxycarbonyl (1 to 6 carbons), carboxy, 5-tetrazolo, and acylsufonamido (i.e. acylaminosulfonyl and sulfonylaminocarbonyl) (1 to 15 carbons) and provided that when the acylsulfonamido contains an aryl the aryl may be further substituted by a member selected from fluoro, chloro, bromo, iodo and nitro; (ee) cycloalkyl containing from 3 to 15 carbons; (ff) alkylureido wherein the alkyl group contains from 1 to 6 carbons; (gg) aralkylureido wherein the aralkyl group contains from 8 to 13 carbons; (hh) arylureido wherein the aryl group contains 6, 10 or 12 carbons; R 3 is an aryl group containing 6, 10 or 12 carbons suitably substituted by acylsulfonamido (i.e. acylaminosulfonyl and sulfonylaminocarbonyl) containing from 1 to 15 carbons, and provided that when the acylsulfonamido contains an aryl the aryl may be further substituted by fluoro, chloro, bromo, iodo or nitro; R 4 and R 6 are independently hydrogen or methyl; n is 0, 1 or 2; and A is selected from the group consisting of ##STR6## and where appropriate, the acid- and base-addition salts thereof and provided that: (1) alkyls may be straight or branched chain; (2) no carbon of an alkyl may be directly bonded to two heteroatoms; and (3) no heteroatom may be directly bonded to a sulfur, nitrogen or oxygen.
Claim 3
Dependent Claim
429 words
A compound as claimed in claim 1 wherein: R 1 is an alkyl group containing 3 carbons; R 2 and R 5 are each selected independently from the group consisting of: (I) an alkyl group containing from 1 to 4 carbons; and (II) an alkyl group containing from 1 to 4 carbons substituted by at least one member selected from the group consisting of: (e) alkanoyl containing from 1 to 3 carbons; (f) arylcarbonyl wherein the aryl contains 6 or 10 carbons; (g) aralkanoyl containing 8 carbons; (h) amido which may be attached to the alkyl group via either a nitrogen or carbon of said amido; (i) alkylcarbonylamino wherein the alkyl group contains from 1 to 2 carbons; (j) alkylaminocarbonyl wherein the alkyl group contains from 1 to 2 carbons; (k) arylcarbonylamino wherein the aryl group contains 6 carbons; (l) aralkylcarbonylamino wherein the aralkyl group contains 7 carbons; (m) arylaminocarbonyl wherein the aryl group contains 6 carbons; (n) aralkylaminocarbonyl wherein the aralkyl group contains 7 carbons; (o) carboxy; (p) aryloxycarbonyl wherein the aryl group contains 6 carbons; (q) aralkoxycarbonyl wherein the aralkoxy group contains 7 carbons; (r) alkanoyloxy containing from 1 to 2 carbons; (s) aroyloxy wherein the aryl portion contains 6 carbons; (t) aralkanoyloxy containing 8 carbons; (u) alkylsulfonamido wherein the alkyl group contains from 1 to 6 carbons; (v) aralkylsulfonamido wherein the aralkyl group contains from 7 to 13 carbons; (w) arylsulfonamido wherein the aryl group contains 6 to 10 carbons; (x) acylsulfonamido containing 1 to 15 carbons; (y) alkoxycarbonyl wherein the alkoxy group contains from 1 to 2 carbons; (z) aralkoxycarbonylamino wherein the aralkoxy group contains 7 carbons; (aa) aryloxycarbonylamino wherein the aryloxy group contains 6 carbons; (bb) alkoxycarbonylamino wherein the alkyloxy group contains from 1 to 3 carbons; (cc) aryl containing 6 or 10 carbons; (dd) aryl containing 6 to 10 carbons and substituted by 1 to 3 members selected from the group consisting of chloro, bromo, iodo, fluoro, trifluoromethyl, hydroxy, alkyl (1 to 2 carbons), alkoxy (1 to 2 carbons), alkoxycarbonyl (2 to 3 carbons), carboxy, 5-tetrazolo and acylsufonamido (1 to 15 carbons); (ee) cycloalkyl containing from 3 to 15 carbons; (ff) alkylureido wherein the alkyl group contains from 1 to 2 carbons; (gg) aralkylureido wherein the aralkyl group contains 7 carbons; (hh) arylureido wherein the aryl group contains 6 or 10 carbons; and R 3 is an aryl group containing 6 or 10 carbons suitably substituted by acylsulfonamido containing from 1 to 15 carbons; R 4 and R 6 are each hydrogen; n=1; and A is selected from the group consisting of ##STR7##
Claim 4
Dependent Claim
163 words
A compound as claimed in claim 1 wherein: R 1 is isopropyl; R 2 is selected from the group consisting of: (I) an alkyl group containing 2 to 3 carbons; (II)(q) ethyl substituted by aralkoxycarbonyl wherein the aralkoxy group contains 7 carbons; (w) butyl substituted by an arylsulfonamido wherein the aryl portion has 6 carbons; (x) ethyl substituted by acylsulfonamido containing 7 carbons; (z) butyl substituted by aralkyloxycarbonylamino wherein the aralkoxy portion contains 7 carbons; and (cc) methyl substituted by an aryl containing 6 carbons; R 3 is an aryl group containing 6 carbons substituted by an acylsulfonamido containing 2 carbons, an acylsulfonamido containing 7 carbons, an acylsulfonamido containing 11 carbons, or an acylsulfonamido containing 14 carbons; R 4 is hydrogen; R 5 is selected from the group consisting of: (I) n-butyl; (II)(q) ethyl substituted by aralkoxycarbonyl wherein the aralkoxy contains 7 carbons; and (II)(z) butyl substituted by aralkyloxycarbonylamino wherein the aralkyl group contains 7 carbons; A is as defined above; and n=1.
Claim 5
Dependent Claim
37 words
A compound as claimed in claim 1 selected from the group consisting of: (a) 3(RS)-[4-(Methylsulfonylaminocarbonyl)phenylaminocarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (b) 3(RS)-[4-(Phenylsulfonylaminocarbonyl)phenylaminocarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (c) 3(RS)-[[4-[(1-Naphthylsulfonyl)aminocarbonyl]phenyl]aminocarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (d) 3(RS)-4-[(4-Nitrophenyl)sulfonylaminocarbonyl]phenylcarbonyl-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (e) 3(RS)-[4-(Phenylsulfonylaminocarbonyl)phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (f) 3(RS)-[4-[(4-Bromophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (g) 3(RS)-[4-[(4-Chlorophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (h) 3S(or R)-[4-(Phenylsulfonylaminocarbonyl)phenylaminocarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (i) 3S(or R)-[4-[(4-Bromophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; and (j) 3S(or R)-[4-[(4-Chlorophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide.
Claim 6
Dependent Claim
26 words
A compound as claimed in claim 5 selected from the group consisting of: (1) 3(RS)-[[4-[(1-Naphthylsulfonyl)aminocarbonyl]phenyl]aminocarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (2) 3(RS)-[4-[(4-Bromophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (3) 3(RS)-[4-[(4-Chlorophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; (4) 3S(or R)-[4-[(4-Bromophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide; and (5) 3S(or R)-[4-[(4-Chlorophenyl)sulfonylaminocarbonyl]phenylcarbonyl]-L-valyl-N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]-L-prolinamide.
Claim 7
Dependent Claim
26 words
A compound as claimed in claim 1 wherein said acid addition salt is one formed with hydrochloric, hydrobromic, sulfuric, nitric, citric, maleic, fumaric or acetic acid.
Claim 8
Dependent Claim
34 words
A compound as claimed in claim 1 wherein said base addition salt is one formed with an alkali metal hydroxide, alklai metal carbonate, alkali metal bicarbonate, alkaline earth hydroxide or an organic amine salt.
Claim 9
Dependent Claim
27 words
A pharmaceutical composition comprising a compound of claim 1 in an amount sufficient to inhibit human leukocyte elastase in association with a non-toxic pharmaceutically-acceptable diluent or carrier.
Claim 10
Dependent Claim
23 words
A method of treating emphysema in a living mammal comprising administering to the mammal an effective amount of a compound of claim 1.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-03-19 | 1993-09-18 | 1994-03-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-03-19 | 1997-09-18 | 1998-03-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-03-19 | 2001-09-18 | 2002-03-20 | $7700.00 | Window Closed / Lapsed |